These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10093509)
1. Development and characterization of monoclonal antibodies to foot and mouth disease virus type 'C'. Saha SN; Natarajan C Indian J Exp Biol; 1998 Dec; 36(12):1258-63. PubMed ID: 10093509 [TBL] [Abstract][Full Text] [Related]
2. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1. Butchaiah G; Rao BU Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of monoclonal antibodies to foot-and-mouth disease virus type Asia-1. Amineva SP; Davydova NL; Mamatkulova LU; Globenko LA; Mishchenko VA Biochemistry (Mosc); 1997 May; 62(5):469-73. PubMed ID: 9275286 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains. Rana SK; Bagchi T Vet Immunol Immunopathol; 2008 Apr; 122(3-4):241-9. PubMed ID: 18291535 [TBL] [Abstract][Full Text] [Related]
6. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related]
7. [Development and characterization of monoclonal antibodies against VP1 protein of AsiaI type foot-and-mouth virus]. Lin T; Chang HY; DU HF; Shao JJ; DU JZ; Cong GZ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1034-7. PubMed ID: 17988586 [TBL] [Abstract][Full Text] [Related]
8. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. Stave JW; Card JL; Morgan DO J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926 [TBL] [Abstract][Full Text] [Related]
9. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope. Das BR; Pattnaik B; Venkataramanan R; Rai DV Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400 [TBL] [Abstract][Full Text] [Related]
10. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Yang M; Clavijo A; Suarez-Banmann R; Avalo R Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972 [TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies against equine influenza A/Equi-2 (H3N8) Indian isolate. Singh BK; Sinclair R; Gupta AK; Uppal PK; Yadav MP; Mumford JA Indian J Exp Biol; 1993 Sep; 31(9):774-5. PubMed ID: 8276447 [TBL] [Abstract][Full Text] [Related]
12. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477 [TBL] [Abstract][Full Text] [Related]
13. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. Cartwright B; Morrell DJ; Brown F J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284 [TBL] [Abstract][Full Text] [Related]
14. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. Cartwright B; Chapman WG; Brown F J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825 [TBL] [Abstract][Full Text] [Related]
15. Production and potential use of monoclonal antibodies against polio viruses. Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107 [TBL] [Abstract][Full Text] [Related]
16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs. Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133 [TBL] [Abstract][Full Text] [Related]
17. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362 [TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Crowther JR; Rowe CA; Butcher R Epidemiol Infect; 1993 Oct; 111(2):391-406. PubMed ID: 7691630 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of monoclonal antibodies to spring viraemia of carp virus. Chen ZY; Liu H; Li ZQ; Zhang QY Vet Immunol Immunopathol; 2008 Jun; 123(3-4):266-76. PubMed ID: 18378003 [TBL] [Abstract][Full Text] [Related]
20. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Cartwright B; Chapman WG; Sharpe RT Res Vet Sci; 1982 May; 32(3):338-42. PubMed ID: 6179141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]